Advanced Pharma CR, LLC   Report issue

For profit Phase 1
Founded: Miami FL United States (1992)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT01948024
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Advanced Pharma CR LLC | Advanced Pharma CR, LLC

Active Ingredients

Drugs in Phase 1 Trials (4)

asenapine (saphris) (1 trial)

bld-0409 (1 trial)

nintedanib (ofev) (1 trial)

pirfenidone (esbriet) (1 trial)

Drugs in Other Trials (1)

axa4010 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 1)

Schizophrenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 5